TrialHepatology (Baltimore, Md.)2018

Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection.

Hidenori Toyoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.